Lodge gains early career award from U.S. pharmacology society
SAN ANTONIO (Jan. 22, 2015) — Daniel Lodge, Ph.D., a psychiatric disorders researcher at The University of Texas Health Science Center at San Antonio, will receive an early career investigator award this year from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Dr. Lodge, who discovered that transplanting stem cells into the rat brain restored functions that are abnormal in schizophrenia, will be honored at the ASPET annual meeting beginning April 28 in Boston. His award is from ASPET’s Neuropharmacology Division.
Dr. Lodge also was invited to become a member-at-large on the ASPET Neuropharmacology Executive Committee in 2016.
Dr. Lodge is an assistant professor of pharmacology in the School of Medicine at the UT Health Science Center and a member of the institution’s Center for Biomedical Neuroscience. He earned his Ph.D. in 2003 at the University of Monash in his native Australia and completed a postdoctoral fellowship in neuroscience at the University of Pittsburgh.
The University of Texas Health Science Center at San Antonio, one of the country’s leading health sciences universities, ranks in the top 13 percent of academic institutions receiving National Institutes of Health (NIH) funding. The university’s schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have produced more than 31,000 graduates. The $787.7 million operating budget supports eight campuses in San Antonio, Laredo, Harlingen and Edinburg. For more information on the many ways “We make lives better®,” visit www.uthscsa.edu.